Hematology/Oncology

Top Story

New targets, treatment strategies create ‘exciting time’ in triple-negative breast cancer

New targets, treatment strategies create ‘exciting time’ in triple-negative breast cancer
August 17, 2019
In the Journals

Teratoma linked to higher cumulative incidence of germ cell tumor-related death

August 16, 2019
Teratoma appeared associated with a higher cumulative incidence of disease-related death among men with nonseminomatous germ cell primary tumors, according to results of…
FDA News

FDA approves Inrebic for myelofibrosis

August 16, 2019
The FDA today approved fedratinib for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. “Myelofibrosis can cause…
In the Journals

Avoid skin markings in dermoscopic images for analysis, training by convolutional neural networks

August 16, 2019
Melanoma probability scores increased due to standard skin markings from surgical ink and were associated with a significant reduction in the specificity of a…
Feature

Ionizing radiation may damage stem cells ‘critically involved in wound healing’

August 16, 2019
In situ damage to skin-derived mesenchymal stem cells during neoadjuvant or adjuvant radiotherapy appeared to have a significant effect on the pathogenesis of slow or…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Bristol-Myers Squibb.

For patients diagnosed with metastatic melanoma, the lifetime incidence of brain metastasis is more than 50% and is…
More »
Video
Meeting News

VIDEO: Early steroids may reduce severe side effects among patients who receive CAR T-cell therapy

July 13, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME ABIM MOC

Ace the Case: A 44-Year-Old Man With a History of Melanoma and a New Onset of Brain Metastases

There is no commercial support for this activity.

Ace the Case: A 44-Year-Old Man With a History of Melanoma and a New Onset of Brain Metastases
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next